Hiroshi Asanuma Selected Research

Charybdotoxin (ChTX)

12/2004	Opening of Ca2+-activated K+ channels is involved in ischemic preconditioning in canine hearts.
6/2003	Eicosapentaenoic acid reduces myocardial injury induced by ischemia and reperfusion in rabbit hearts.
9/2002	Amelioration of ischemia- and reperfusion-induced myocardial injury by the selective estrogen receptor modulator, raloxifene, in the canine heart.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Asanuma Research Topics

Disease

32	Heart Failure 01/2019 - 10/2003
22	Infarction (Infarctions) 10/2018 - 01/2002
17	Reperfusion Injury 12/2017 - 01/2002
16	Neoplasms (Cancer) 09/2021 - 03/2002
16	Myocardial Infarction 10/2018 - 01/2002
15	Ischemia 10/2020 - 01/2002
11	Myocardial Ischemia (Ischemic Heart Diseases) 05/2015 - 07/2002
10	Fibrosis (Cirrhosis) 01/2019 - 10/2006
9	Hypertrophy 01/2019 - 09/2002
9	Cardiomegaly (Heart Hypertrophy) 01/2016 - 01/2002
6	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2018
6	Diabetes Mellitus 01/2019 - 10/2006
6	Glucose Intolerance 08/2017 - 02/2006
6	Coronary Occlusion 12/2004 - 01/2002
5	Prostatic Neoplasms (Prostate Cancer) 04/2021 - 10/2015
5	Body Weight (Weight, Body) 10/2008 - 09/2002
4	Hypotension (Low Blood Pressure) 11/2021 - 10/2007
4	Ureteral Obstruction 10/2011 - 09/2009
4	Ventricular Fibrillation 06/2006 - 01/2002
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022 - 10/2006
3	Bradycardia 01/2019 - 02/2009
3	Urinary Bladder Neoplasms (Bladder Cancer) 10/2015 - 02/2003
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2015 - 05/2010
2	Hemorrhage 07/2022 - 10/2015
2	Left Ventricular Dysfunction 09/2020 - 07/2006
2	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 11/2018 - 07/2010
2	Stroke (Strokes) 10/2018 - 08/2017
2	Unstable Angina 10/2018 - 08/2017
2	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2015
2	Inflammation (Inflammations) 01/2016 - 09/2009
2	Hyperplasia 10/2015 - 04/2005
2	Hypoxia (Hypoxemia) 02/2015 - 01/2014
2	Chronic Renal Insufficiency 11/2014 - 07/2010
2	Cardiac Arrhythmias (Arrythmia) 04/2013 - 06/2006
2	Insulin Resistance 08/2012 - 05/2009

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2002
12	Adenosine (Adenocard)FDA LinkGeneric 09/2019 - 01/2002
8	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2017 - 01/2002
7	Adenosine Triphosphate (ATP)IBA 02/2015 - 09/2002
6	Glucose (Dextrose)FDA LinkGeneric 09/2020 - 02/2006
6	5'-Nucleotidase (5' Nucleotidase)IBA 06/2008 - 09/2003
6	Phosphotransferases (Kinase)IBA 06/2006 - 09/2002
5	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2017 - 01/2012
5	Purinergic P1 Receptors (Adenosine Receptor)IBA 05/2015 - 01/2002
5	NG-Nitroarginine Methyl Ester (L-NAME)IBA 06/2003 - 01/2002
4	CollagenIBA 01/2019 - 09/2009
4	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2019 - 05/2013
4	CytokinesIBA 01/2016 - 06/2011
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 09/2009
4	Raloxifene Hydrochloride (Evista)FDA Link 06/2004 - 01/2002
4	Selective Estrogen Receptor Modulators (SERM)IBA 06/2004 - 01/2002
3	C-Reactive ProteinIBA 08/2021 - 01/2018
3	PotassiumIBA 01/2020 - 09/2002
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2019 - 09/2002
3	AdiponectinIBA 10/2018 - 12/2009
3	Hormones (Hormone)IBA 02/2017 - 05/2013
3	Pharmaceutical PreparationsIBA 01/2016 - 04/2005
3	Glucagon-Like Peptide 1 (GLP 1)IBA 05/2015 - 05/2013
3	Anti-Arrhythmia AgentsIBA 04/2013 - 01/2005
3	Angiotensin IIIBA 01/2012 - 10/2003
3	Interleukin-18 (Interleukin 18)IBA 10/2011 - 09/2009
3	salicylhydroxamic acid (SHAM)IBA 10/2011 - 06/2011
3	Cadherins (E-Cadherin)IBA 06/2011 - 09/2009
3	Histamine (Histamine Dihydrochloride)FDA Link 11/2010 - 05/2006
3	WortmanninIBA 06/2006 - 10/2004
3	KATP ChannelsIBA 12/2005 - 01/2003
3	Protein Kinase CIBA 12/2005 - 07/2004
3	Charybdotoxin (ChTX)IBA 12/2004 - 09/2002
3	8-(4-sulfophenyl)theophyllineIBA 10/2004 - 01/2002
3	Nitric Oxide Synthase (NO Synthase)IBA 08/2004 - 01/2002
3	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 04/2003 - 09/2002
2	HDL CholesterolIBA 09/2020 - 08/2012
2	AldosteroneIBA 01/2020 - 07/2005
2	Uric Acid (Urate)IBA 06/2019 - 08/2012
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 03/2013
2	VildagliptinIBA 01/2019 - 05/2013
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2019 - 05/2013
2	Methylprednisolone FDA LinkGeneric 01/2019 - 03/2013
2	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 11/2018 - 01/2002
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2018 - 05/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 03/2002
2	HydrogenIBA 06/2017 - 06/2012
2	Fibroblast Growth Factor-23IBA 02/2017 - 11/2014
2	Messenger RNA (mRNA)IBA 01/2016 - 07/2010
2	Liposomes (Liposome)IBA 01/2016 - 02/2009
2	AMP-Activated Protein KinasesIBA 01/2015 - 05/2009
2	IncretinsIBA 01/2015 - 05/2013
2	human NPPA protein (carperitide)IBA 08/2014 - 12/2009

Therapy/Procedure

21	Therapeutics 07/2022 - 01/2002
6	Percutaneous Coronary Intervention 12/2022 - 02/2004
5	Nephrectomy 10/2020 - 03/2006
4	Prostatectomy (Retropubic Prostatectomy) 11/2022 - 01/2019
4	Intravenous Administration 04/2013 - 01/2005
3	Adrenalectomy 11/2021 - 04/2012
3	Castration 04/2021 - 07/2020
2	Catheters 07/2022 - 03/2007
2	Kidney Transplantation 03/2020 - 03/2013
2	Secondary Prevention 10/2018 - 05/2010
2	Drug Therapy (Chemotherapy) 01/2018 - 08/2016
2	Ligation 01/2012 - 04/2005